DIFFERENTIAL THERMAL, SOLUBILITY, AND AGING STUDIES ON VARIOUS SOURCES OF DIGOXIN AND DIGITOXIN POWDER - BIOPHARMACEUTICAL IMPLICATIONS

被引:44
作者
CHIOU, WL [1 ]
KYLE, LE [1 ]
机构
[1] UNIV ILLINOIS, MED CTR, COLL PHARM, DEPT PHARM, CHICAGO, IL 60612 USA
关键词
Cardiotonic agents—digoxin and digitoxin; stability studies; various commercial powders; Digitoxin—stability studies; temperature; solubility; aging; Digoxin—stability studies; Stability—digoxin; digitoxin;
D O I
10.1002/jps.2600681008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Unlike most organic compounds, both digoxin and digitoxin melted over a wide temperature range, with the widest range being 88 and 33° for both compounds, respectively. Furthermore, the melting ranges varied markedly among several untriturated powders obtained from commercial sources and after recrystallization. Trituration produced dramatically sharper and generally lower melting temperatures. Apparent equilibrium solubility also varied considerably among different untriturated compounds. Correlation between solubility and final melting temperature was found. Results from dynamic solubility studies were used to explain the failure of trituration to enhance the apparent equilibrium solubility in certain samples. Storage at room temperature increased the melting points and decreased aqueous solubilities. Several reasons such as the presence of polymorphic and amorphous forms, crystal defects, impurities, and solvate formation were postulated to explain the findings. In a preliminary study, the in vitro dissolution rates of two commercial tablet products stored at elevated temperatures for 4‐8 weeks progressively decreased. Biopharmaceutical implications and areas for further studies are discussed. Copyright © 1979 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:1224 / 1229
页数:6
相关论文
共 25 条
[1]  
[Anonymous], 1977, J AM PHARM ASSOC, V17, P635
[2]   ISOLATION AND QUANTITATION OF PICOMOLE QUANTITIES OF DIGOXIN, DIGITOXIN AND THEIR METABOLITES BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
CASTLE, MC .
JOURNAL OF CHROMATOGRAPHY, 1975, 115 (02) :437-445
[3]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[4]   ORAL ABSORPTION OF GRISEOFULVIN IN DOGS - INCREASED ABSORPTION VIA SOLID DISPERSION IN POLYETHYLENE GLYCOL-6000 [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (07) :937-+
[6]   DIFFERENTIAL THERMAL-ANALYSIS AND X-RAY-DIFFRACTION STUDIES OF GRISEOFULVIN SUCCINIC ACID SOLID DISPERSIONS [J].
CHIOU, WL ;
NIAZI, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (03) :498-501
[7]   PHASE DIAGRAM AND DISSOLUTION-RATE STUDIES ON SULFATHIAZOLE-UREA SOLID DISPERSIONS [J].
CHIOU, WL ;
NIAZI, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1333-&
[8]   EFFECT OF PARTICLE-SIZE REDUCTION ON DIGOXIN CRYSTAL PROPERTIES [J].
FLORENCE, AT ;
SALOLE, EG ;
STENLAKE, JB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1974, 26 (06) :479-480
[9]   CHANGES IN CRYSTALLINITY AND SOLUBILITY ON COMMINUTION OF DIGOXIN AND OBSERVATIONS ON SPIRONOLACTONE AND ESTRADIOL [J].
FLORENCE, AT ;
SALOLE, EG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (08) :637-642
[10]  
GREENBLATT D J, 1976, Clinical Pharmacokinetics, V1, P36, DOI 10.2165/00003088-197601010-00004